Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
6.74
+0.15 (2.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$99,412
Profits / Employee
-$3,823,143
Market Cap
6.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TransCode Therapeutics | 12 |
| Processa Pharmaceuticals | 12 |
| MetaVia | 8 |
| Immuron | 7 |
| Indaptus Therapeutics | 5 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| PharmaCyte Biotech | 2 |
ADXN News
- 7 days ago - Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model - GlobeNewsWire
- 3 months ago - Addex Therapeutics (ADXN) Publishes Promising Research on Anxiety Treatment - GuruFocus
- 3 months ago - Addex Therapeutics (ADXN) Advances NTX-253 into Clinical Trials for Schizophrenia - GuruFocus
- 3 months ago - Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia - GlobeNewsWire
- 4 months ago - Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co. - GlobeNewsWire
- 5 months ago - Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... - GuruFocus
- 5 months ago - Q3 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Earnings Scheduled For December 4, 2025 - Benzinga